Back to search

Netherlands· NL-9b6fbe311c9d

Bactroban 2% Neuszalf 20 mg/g

A mupirocin product containing mupirocine calcium 2-water, registered in Netherlands by GlaxoSmithKline B.V.. The same ATC class is registered in 10 of our 19 countries.

ATC R01AX06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedBactroban 2% Neuszalf 20 mg/gATCR01AX06REGISTER NO.NL-9b6fbe311c9dPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Mupirocin is registered in 10 of 19 countries.

Countries holding a registration under ATC R01AX06 (mupirocin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose

Mupirocin · ATC R01AX06

10 / 19 countries

  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mupirocin costs, country by country.

Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Mupirocin · price per daily dose (3 mg)

USD · FX 28 Sept 2026

  • CZ Czechia$0.0025
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
MUPIROCINE CALCIUM 2-WATER
Manufacturer
GlaxoSmithKline B.V.
Country
Netherlands (NL)
ATC code
R01AX06
ATC class
Mupirocin
Defined daily dose
3 mg, N
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    13761

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

151 interactions on record for mupirocin.

Graded by severity as the source publishes them — 151 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Mupirocin · interactions on record

151 records

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Mupirocin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mupirocin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Bactroban, Infectopyoderm
  • Belgium · Bactroban
  • Bulgaria · Бактробан, Мупиродермал
  • Cyprus · Bactroban, Mupiderm
  • Czechia · Bactroban, Bactroban Nasal
  • Germany · Infectopyoderm, Mupirocin Infectopharm
  • Denmark · Bactroban
  • Spain · Bacnas, Bactroban
  • Finland · Bactroban Nasal
  • France · Bactroban, Mupiderm
  • United Kingdom (Northern Ireland) · Bactroban, Mupirocin Aspire Pharma
  • Greece · Bactroban, Bactrocine
  • Croatia · Betrion, Mirobact
  • Hungary · Bactroban, Mupirocin Infectopharm
  • Ireland · Bactroban
  • Iceland · Bactroban, Bactroban Nasal
  • Italy · Bactroban, Bactroban Nasale
  • Luxembourg · Bactroban
  • Latvia · Munipix
  • Malta · Bactroban, Mupironasal
  • Poland · Bactroban, Mubactin
  • Portugal · Bactroban, Impetine®
  • Sweden · Bactroban, Bactroban Nasal
  • Slovenia · Betrion
  • Slovakia · Bactroban

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/73e061b9-bcf4-4900-8aa0-5aa629028556
GET /v1/drugs/73e061b9-bcf4-4900-8aa0-5aa629028556?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Neuszalf",
  "route": "Nasaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h13761_smpc.pdf",
  "strength": null,
  "atc_label": "Mupirocin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg13761",
  "excipients": [
    "SOFTISAN 649",
    "VASELINE, WIT"
  ],
  "substances": [
    "MUPIROCINE CALCIUM 2-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h13761.pdf",
  "authorised_at": "1990/05/17",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "13761",
  "additional_monitoring": "N"
}

See everything about mupirocin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.